(Credit-Canva)
The current measles outbreak has gripped US states like Texas and New Mexico leaving people worried whether it would become a new pandemic. According to the Texas Department of State Health Services as of February 21, 90 cases were diagnosed in the last month in the South Plains area, with at least 77 of them were reported in children and teens under 17.
Measles is highly contagious and can be deadly. The outbreak, which started spreading in late January, has resulted in multiple hospitalizations, with at least nine confirmed cases and three probable cases as of early February. Health officials caution that at least one in five infected individuals will have to be hospitalized, highlighting the severity of the situation.
Misinformation surrounding vaccines and with the new Trump administration anti-vaccine campaigs, has causing parents to hesitate or refuse vaccination.
Furthermore, the country down under Australia is also witnessing a surge in measles cases as health officials in Sydney have issued an urgent alert, urging residents to watch for measles symptoms after an infected individual visited several places in Sydney over the last seven days.
Authorities report that the traveller had returned from South East Asia where there are ongoing outbreaks of measles.
Key symptoms of measles include fever, a runny nose, sore eyes, and a cough. Typically, a red, blotchy rash appears three to four days later, spreading from the head down to the body. Symptoms can manifest between 7 and 18 days after exposure.
Anyone who experiences these symptoms after potential exposure should immediately contact their doctor or emergency department. It is crucial to call ahead before visiting to avoid potentially exposing others in the waiting room. Dr. Selvey also highlighted that ongoing measles outbreaks are occurring in various parts of the world, making awareness and prompt action essential.
According to CDC everyone should get the MMR vaccine. It protects you from measles, mumps, and rubella. Getting vaccinated helps stop these diseases from spreading. There are two safe MMR vaccines available. They work the same way, so it doesn't matter which one you get. Kids can also get a shot that protects against chickenpox too, but this is only for children.
All children should get two MMR shots. The first shot should be given when they are between 12 and 15 months old. The second shot should be given when they are between 4 and 6 years old. If needed, the second shot can be given earlier, but it must be at least 28 days after the first shot.
Students going to college or other schools after high school, need two shots if they are not already immune. The shots must be at least 28 days apart.
Most adults need at least one MMR shot. Some adults need two shots, especially those who work in healthcare, travel a lot, or go to college. These people should get two shots, with 28 days between them.
Anyone traveling to other countries should make sure they are protected. Babies 6 to 11 months old should get one shot before traveling. Kids 12 months and older, teens, and adults need two shots, with 28 days between them.
People who work in healthcare should have proof that they are immune to measles, mumps, and rubella. If they are not immune, they need two MMR shots, spaced 28 days apart.
Women who might get pregnant should talk to their doctor about the MMR vaccine. It's safe to get the shot while breastfeeding.

Credit: iStock
Around 4.9 million people aged 18 years and over (9.8%) smoked cigarettes in the UK in 2025, down from 10.6% in 2024, continuing the long-term decline in smoking, according to the latest report from the UK’s Office for National Statistics (ONS).
But as smoking rates fall, vaping has become increasingly common. In Great Britain, around 5.4 million people aged 16 years and over (9.9%) used an e-cigarette daily or occasionally in 2025, according to the ONS Opinions and Lifestyle Survey.
For the second consecutive year, e-cigarette use was higher than cigarette smoking. In 2025, there were around:
The proportion of adults using e-cigarettes has also increased over the longer term, rising from 6.4% in 2020 to 9.9% in 2025.
E-cigarette use was highest among people aged 25 to 34 years, with 16.4% reporting daily or occasional use.Overall, 6.5% of people aged 16 and over reported vaping daily in 2025, slightly down from 6.7% in 2024. Another 3.4% reported occasional use, up from 3.3%.
The ONS data also show that vaping is not limited to current smokers. In 2025, 7.2% of people reported having previously used an e-cigarette, up from 6.6% in 2024, while the proportion who had never used one fell slightly from 83.4% to 83.0%.
Vaping is often perceived as a cleaner alternative to smoking because e-cigarettes do not burn tobacco. However, the aerosol produced by these devices can contain substances that may affect the lungs and cardiovascular system.
Unlike harmless water vapour, e-cigarette aerosol may contain:
“Inhaling these substances directly into the lungs introduces not just nicotine, but also numerous potentially carcinogenic and lung-damaging compounds,” said Dr. Arun Chowdary Kotaru, Head and Senior Consultant of Pulmonology & Sleep Medicine.
“This is not harm reduction—it’s harm diversification.”
Vaping was initially promoted as a smoking-cessation aid and is generally considered less harmful than smoking combustible cigarettes. However, e-cigarettes are not risk-free.
The concern is particularly relevant for people who have never smoked. For them, taking up vaping can introduce a new source of nicotine exposure and dependence rather than replacing an existing smoking habit.
“Vaping is not harmless,” warns Dr. Arun. “Even if it may contain fewer toxic chemicals than traditional cigarettes, it still delivers a cocktail of harmful substances that are anything but safe.”
Nicotine exposure is also a concern for adolescents because the brain continues developing into the mid-20s.
“The teenage brain is still developing until around the age of 25,” explains Dr. Kotaru. “Nicotine interferes with areas responsible for learning, impulse control, and mood regulation. Early exposure can also set the stage for a lifelong struggle with addiction, increasing vulnerability to other substance abuse later in life.” .
Credit: iStock
Raw, unpasteurized milk has gained traction in the US over the past two years despite warnings about its health risks. The American Academy of Pediatrics (AAP) has renewed its call for a ban on the sale and distribution of raw milk and dairy products, including raw cheeses.
Recent cases have highlighted the risks associated with raw milk. Two California girls — 17-month-old Brooklyn and 6-year-old Victoria — were hospitalized with near-fatal E. coli infections after drinking raw goat milk. Hundreds of people have fallen ill across nine states in the past two years after consuming raw milk or products made from it.
“Claims that raw milk provides superior health benefits are not supported by scientific evidence,” the AAP said.
In a policy statement published online ahead of print in the November 2026 issue of Pediatrics, the AAP said unpasteurized milk, cheese and other raw dairy products are unsafe, particularly for young children and people who are pregnant or breastfeeding.
“Nearly half of illnesses caused by raw dairy consumption occur in people under age 20 – and a significant share of those cases are in children under 5,” said Adam J. Ratner, MD, MPH, FAAP, lead author.
“These illnesses can be severe and lead to life-threatening complications. Pasteurization … dramatically reduces the risks without taking away the nutritional value families rely on.”
The updated guidance also highlights H5N1, or highly pathogenic avian influenza, as an emerging risk associated with raw milk. Sales and distribution of raw milk remain legal in at least 27 states.
The virus can be transmitted from infected dairy cattle into milk, where it can reach high concentrations and remain detectable in refrigerated raw milk for up to five weeks.
During the 2024 US dairy outbreak, infectious H5N1 was detected in nearly one-quarter of raw milk samples in affected areas. However, FDA and USDA testing of commercial pasteurized milk found no viable virus, showing that high-temperature, short-time (HTST) pasteurization neutralizes H5N1.
No human cases of H5N1 infection from consuming raw milk have been confirmed to date, but the AAP considers it a credible emerging threat.
Read More: Second Plague Death Reported As Russia Denies Outbreak
Unpasteurized milk can contain Listeria, E. coli, Salmonella, Campylobacter and Brucella. These infections can cause severe illness, hospitalization, miscarriage and death, particularly among young children, pregnant people and those with weakened immune systems.
Listeriosis is estimated to be 12 to 14 times more common during pregnancy than in the general population and can cause miscarriage, stillbirth, premature delivery or severe illness in newborns.
AAP Says Pasteurized Dairy Is Safest
“Parents may choose raw milk because they have heard it is healthier or more natural, but the scientific evidence tells a different story,” said Mark R. Corkins, MD, FAAP, co-author of the policy statement.
“Pasteurized dairy products provide the same essential nutrients without exposing children and families to preventable infections from dangerous bacteria and viruses. For infants, children and pregnant people, pasteurized dairy products are clearly the safest choice.”
Credit: AI
Women living with HIV are six times more likely to be infected with HPV. They are also twice as likely to die from invasive cervical cancer. Hence, a recent study published in The Lancet HIV has sparked hope after it found that HPV vaccine can provide long-term safety to women living with HIV.
Emphasising on the importance of HPV vaccination among women in this sub-section, the study followed women with HIV for 9 years after they received HPV vaccine, becoming the longest study that analyses how this vaccine works in this population. Until now, researchers had limited evidence about how this vaccine's efficacy on women with HIV.
Also read: India-Made HPV Vaccine CERVAVAC Gets WHO Prequalification: Serum Institute
A team of researchers from the UBC Faculty of Medicine followed 293 Canadian women with HIV through 14 HIV and gynecological treatment clinics across the country. They found that the vaccine evoked a strong immune response that persisted for a long time.
The rates of HPV infection and genital warts were very low among women who received all the three doses did not already have the strains of HPV targeted by the vaccine.
Additionally, no participants developed serious precancerous changes to the cervix caused by those HPV strains.
Maintaining an undetectable HIV viral load was also crucial for sustaining HPV antibody levels over time, according to the researchers. The finding highlighted the importance of continued access to appropriate HIV treatment and care.
“We’ve known for some time that HPV vaccines are safe and highly effective, but we didn’t have long-term evidence to show how lasting that protection is for women living with HIV,” said first author Dr. Elisabeth McClymont, assistant professor in the UBC Faculty of Medicine’s department of obstetrics and gynaecology and department of pediatrics. “Our findings are incredibly reassuring. Even in a population whose immune systems can be affected by HIV, vaccination provided strong protection against HPV infection and cervical cancer for many years.”
Also read: H. pylori, HPV Among Five Infections Behind 1 In 8 Cancers Worldwide: Lancet
The findings have significant relevance globally as almost 20 million women and girls are living with HIV worldwide. It is also uneven as regions like sub-Saharan Africa face a heavier burden with limited access to cervical cancer screening and treatment.
“Cervical cancer is preventable, yet it continues to take lives in Canada and around the world, particularly in places where HIV rates are higher and access to screening and prevention is limited,” said senior author Dr. Deborah Money, professor and head of the UBC Faculty of Medicine’s department of obstetrics and gynaecology. “We now have concrete evidence that HPV vaccination works very well for women living with HIV over the long term. Making this vaccine more accessible and acceptable for those who need it most can help us prevent unnecessary deaths and move closer to eliminating cervical cancer globally.”
Most cervical cancer cases are caused by infection from oncogenic types of human papillomavirus (HPV). HPV is a common sexually transmitted infection which can affect the throat, skin, genitals, and anal region.
Persistent HPV infection may lead to precancerous changes in the cervix, which if left untreated, is most likely to result in cervical cancer within a span of two decades. Women with HIV, with weakened immune systems, may develop cervical cancer within 5 to 10 years.
According to the World Health Organisation, cervical cancer is the fifth most diagnosed cancer forms among women. In 2024, more than 600,000 cases and 280,000 deaths were reported. The health body emphasises on prevention through HPV vaccination and regular screening.
© $2026 Times Horizon Private Limited